Progress in 3D Bioprinting Technology for Osteochondral Regeneration.

Markel Lafuente-Merchan1,2,3, Sandra Ruiz-Alonso1,2,3, Fátima García-Villén1,2,3

  • 1NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.

Pharmaceutics
|August 26, 2022
PubMed
Summary

Osteoarthritis (OA) causes cartilage and bone degradation, leading to pain and immobility. 3D bioprinting offers a promising new therapeutic approach for osteochondral regeneration, potentially treating OA.

Related Concept Videos